101
102
103
de Boer, Alyse, van den Bosch, Aletta M R, Mekkes, Nienke J, Fransen, Nina L, Dagkesamanskaia, Ekaterina, Hoekstra, Eric, Hamann, Jörg, Smolders, Joost, Huitinga, Inge, Holtman, Inge R
Veröffentlicht in: de Boer , A , van den Bosch , A M R , Mekkes , N J , Fransen , N L , Dagkesamanskaia , E , Hoekstra , E , Hamann , J , Smolders , J , Huitinga , I & Holtman , I R 2024 , ' Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions ' , Acta Neuropathologica , vol. 147 , no. 1 , pp. 90 . https://doi.org/10.1007/s00401-024-02742-w;
2024
Veröffentlicht in: de Boer , A , van den Bosch , A M R , Mekkes , N J , Fransen , N L , Dagkesamanskaia , E , Hoekstra , E , Hamann , J , Smolders , J , Huitinga , I & Holtman , I R 2024 , ' Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions ' , Acta Neuropathologica , vol. 147 , no. 1 , pp. 90 . https://doi.org/10.1007/s00401-024-02742-w;
2024
104
Beije, N., Kraan, J., Taal, W., van der Holt, B., Oosterkamp, H. M., Walenkamp, A. M., Beerepoot, L., Hanse, M., van Linde, M. E., Otten, A., Vernhout, R. M., de Vos, F. Y. F., Gratama, J. W., Sleijfer, S., van den Bent, M. J.
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , B , Oosterkamp , H M , Walenkamp , A M , Beerepoot , L , Hanse , M , van Linde , M E , Otten , A , Vernhout , R M , de Vos , F Y F , Gratama , J W , Sleijfer , S & van den Bent , M J 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Jounal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , B , Oosterkamp , H M , Walenkamp , A M , Beerepoot , L , Hanse , M , van Linde , M E , Otten , A , Vernhout , R M , de Vos , F Y F , Gratama , J W , Sleijfer , S & van den Bent , M J 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Jounal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
105
106
107
108
109
110
Gijtenbeek, Rolof G. P., Damhuis, Ronald A. M., Wekken, Anthonie J. van der, Hendriks, Lizza E. L., Groen, Harry J. M., Geffen, Wouter H. van
Veröffentlicht in: Gijtenbeek , R G P , Damhuis , R A M , Wekken , A J V D , Hendriks , L E L , Groen , H J M & Geffen , W H V 2023 , ' Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands : a retrospective, nationwide registry study ' , The Lancet Regional Health – Europe , vol. 27 , no. 1 , 100592 . https://doi.org/10.1016/j.lanepe.2023.100592;
2023
Veröffentlicht in: Gijtenbeek , R G P , Damhuis , R A M , Wekken , A J V D , Hendriks , L E L , Groen , H J M & Geffen , W H V 2023 , ' Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands : a retrospective, nationwide registry study ' , The Lancet Regional Health – Europe , vol. 27 , no. 1 , 100592 . https://doi.org/10.1016/j.lanepe.2023.100592;
2023